PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Innovative mouse model mimicking human-like features of spinal cord injury: efficacy of Docosahexaenoic acid on acute and chronic phases.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31222077 ↗2019Reported benefit

Innovative mouse model mimicking human-like features of spinal cord injury: efficacy of Docosahexaenoic acid on acute and chronic phases.

MouseSpinal cord injuryContusionCD1Femalen = Behaviour n = 8 to 11 per group; immunohistochemistry n = 3…Intraperitoneal0.082 mg/kgFirst dose within 1 hour of surgery

Model: Severe contusion spinal cord injury at thoracic level T10 without laminectomy, delivered with a stereotaxic frame and computer-controlled PinPoint precision impactor (tip #4, velocity 3 m/s, depth 5 mm, dwell time 800 ms)

DHA restored hindlimb locomotor function and the tail-flick reflex in mice that were otherwise permanently paraplegic, reduced gliosis, cavitation and microglial activation, lowered caspase-3, p75NTR and pJNK, and increased regenerated area at 60 days.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.